Core Insights - Aardvark Therapeutics, Inc. has appointed key members to its leadership team to enhance its strategic capabilities as it progresses with its Phase 3 HERO study of ARD-101 for treating hyperphagia associated with Prader-Willi Syndrome [1][2] Leadership Appointments - Timothy Kieffer, Ph.D., appointed as Chief Scientific Officer, brings extensive experience in diabetes mechanisms and translational medicine, having previously served at ViaCyte Inc. and Fractyl Health [2][3] - Danny Villeneuve appointed as Chief Commercial Officer, has over 20 years of commercial leadership experience in the biopharmaceutical industry, notably leading the relaunch of a flagship ADHD product at Ironshore Pharmaceuticals [3] - Terrie Kellmeyer, Ph.D., appointed as Senior Vice President, Regulatory Affairs, has nearly 30 years of regulatory strategy and clinical development expertise, contributing to multiple successful New Drug Applications [4] - Christian Zapf, J.D., appointed as General Counsel, has over 20 years of legal and transactional experience in biotechnology, previously serving at Abpro Corporation and NantWorks [5] Company Overview - Aardvark is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics to suppress hunger for treating Prader-Willi Syndrome and other metabolic diseases [8] - The lead compound, ARD-101, is in Phase 3 clinical development for hyperphagia associated with PWS and is also being studied for hypothalamic obesity [8]

Napoleonville, Louisiana--(Newsfile Corp. - May 19, 2025) - Impact Fusion (OTC Pink: IFUS) As widely reported in the media and noted by concerned lawmakers, the USA is facing a serious infestation of the New World Screwworm Fly. This infestation could wreak havoc on the American beef cattle and dairy industries, as well as impact other mammals. To that end, Agriculture Secretary Betty Rollins has declared an emergency. She has closed the border to beef exports from Mexico.Six of the nation's lawmakers, inc ...

Shares of Team, Inc. (TISI) have gained 3% since reporting results for the first quarter of 2025. This compares with the S&P 500 index’s 1% growth over the same period. However, over the past month, the stock has declined 6.7% against an 11.4% rally in the S&P 500, underperforming the broader market despite near-term post-earnings strength.Team reported total revenues of $198.7 million compared with $199.6 million in the prior-year quarter. However, the company’s net loss widened to $29.7 million, or $6.61 ...

Team (TISI) Q1 2025 Earnings Call May 13, 2025 11:00 AM ET Speaker0 Good day, and welcome to the Team Incorporated First Quarter Update Conference Call. All participants will be in a listen only mode. I would now like to turn the conference over to Mr. Nelson Haight, Executive Vice President and Chief Financial Officer. Please go ahead, sir. Speaker1 Thank you, operator. Good morning, everyone, and welcome to Team Inc. Discussion about our first quarter twenty twenty five operational and financial results. ...

Revenue Performance - Total revenues decreased by $0.9 million or 0.5% from the prior year period, with IHT segment revenue increasing by $6.8 million or 6.8% and MS segment revenue decreasing by $7.7 million or 7.7%[109] - IHT segment revenue growth was driven by a $7.8 million increase in U.S. operations revenue, attributed to higher turnaround and capital projects activity[109] - MS segment revenue decline was mainly due to lower turnaround activities and callout projects in the U.S. and international areas[109] Operating Performance - Operating loss improved by $0.4 million or 6.0% to $6.0 million, with IHT operating income increasing by $3.5 million or 67.7% and MS operating income decreasing by $5.2 million or 127.2%[110] - Corporate operating loss decreased by $2.1 million compared to the prior year period, primarily due to lower personnel and professional services costs[110] - Non-core expenses totaled $3.0 million in Q1 2025, leading to an operating loss of $3.0 million when excluding these items[112] Financial Position - The company regained compliance with NYSE continued listing standards as of March 14, 2025[105] - Total debt and finance obligations increased to $353.6 million as of March 31, 2025, compared to $325.1 million at December 31, 2024[139] - The company is in compliance with its debt covenants as of March 31, 2025, which is crucial for maintaining financial stability[135] Cash Flow and Liquidity - Free cash flow for Q1 2025 was $(30.067) million, compared to $(1.130) million in Q1 2024, showing a significant decline in cash flow[122] - Consolidated cash and cash equivalents of $8.6 million as of May 8, 2025, with total liquidity amounting to $23.8 million[136] - The company’s liquidity assessment indicates sufficient working capital and cash flow to fund operations and service debt for the next twelve months[129] Adjusted Financial Metrics - Adjusted net loss for Q1 2025 was $14.869 million, compared to $14.719 million in Q1 2024, reflecting a slight increase in losses[122] - Consolidated adjusted EBITDA for Q1 2025 was $5.310 million, down from $6.507 million in Q1 2024, indicating a decrease of approximately 18.4%[122] - Segment adjusted EBITDA for the IHT segment increased to $11.624 million in Q1 2025 from $8.349 million in Q1 2024, representing a growth of approximately 39.3%[127] - The MS segment reported an adjusted EBITDA of $3.494 million in Q1 2025, down from $9.147 million in Q1 2024, reflecting a decrease of approximately 61.8%[127] Cash Flow Activities - For the three months ended March 31, 2025, net cash used in operating activities was $28.7 million, a decrease of $30.5 million compared to net cash provided by operating activities of $1.9 million in the 2024 period[140] - Net cash used in investing activities for the three months ended March 31, 2025 was $1.4 million, compared to $3.0 million in the same period of 2024[142] - Net cash provided by financing activities was $11.2 million for the three months ended March 31, 2025, primarily from net borrowings under the Revolving Credit Loans[143] Debt and Refinancing - Loss on debt extinguishment amounted to $11.9 million due to refinancing transactions, including $7.4 million of unamortized debt issuance cost written off[114] - Recent refinancing transactions were completed on March 12, 2025, to improve the company's financial position[133] - Cash flows from financing activities included $8.1 million in debt issuance costs related to refinancing transactions as of March 12, 2025[144] Foreign Exchange and International Operations - The effect of foreign exchange rate changes on cash was positive $0.1 million for the three months ended March 31, 2025, compared to negative $0.3 million in 2024[146] - International cash balances as of March 31, 2025 were $4.8 million, with approximately $1.1 million located in countries with currency or regulatory restrictions[137] Working Capital - The company experienced higher negative working capital impacts of $23.7 million primarily due to an increase in accounts receivable[140]

Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE TEAM, INC. REPORTS FIRST QUARTER 2025 RESULTS SUGAR LAND, TX – May 12, 2025 – Team, Inc. (NYSE: TISI) ("TEAM" or the "Company"), a global, leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights: See the accompanying reconcil ...

SUGAR LAND, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights: Generated first quarter 2025 revenue of $198.7 million and a gross margin of 23.8%.Reported a net loss ...

SALT LAKE CITY, May 9, 2025 /PRNewswire/ -- FatPipe, Inc. FatPipe, Inc. (NASDAQ: FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class, application-aware, secure software-defined wide area network ("SD-WAN") solutions that provide the highest levels of reliability, security, and optimization for Wide Area Networks (WANs), today announced the appointment of its full executive management team as it continues to build on the momentum of its recent Nasdaq listing, scaling operations globally to meet ...

SUGAR LAND, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced that it will issue its first quarter 2025 earnings release on Monday, May 12, 2025 after the close of trading on the New York Stock Exchange. TEAM will host a conference call to discuss its fina ...

BELLINGHAM, Wash., May 07, 2025 (GLOBE NEWSWIRE) -- eXp Realty®,  “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), proudly welcomes John Rota and the Müve Team of Edmonton, Alberta. With 46 agents and 5 staff members, the team closed more than $303 million (CAD) in sales on 686 sides in 2024, and now joins eXp with bold plans for growth and national expansion. “John Rota and the Müve Team are exactly the kind of forward-focused ...